Also trades as: ITRMF (OTC) · $vol 0M
ITRM NASDAQ
Iterum Therapeutics plc
1W: -6.4%
1M: -79.9%
3M: -89.3%
YTD: -89.3%
1Y: -97.2%
3Y: -96.5%
5Y: -99.8%
$0.03
Last traded 2026-04-06 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
#?
of ?
Biotechnology
Technical Signal Map
0 Bullish
1 Neutral
4 Bearish
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| ITRM Iterum Therapeutics plc | — | -0.1 | 285.5 | -104.4 | -2302.3 | — | 5 | N/A | -97.2 |
| JAZZ Jazz Pharmaceuticals plc | $15B | 15.5 | 22.1 | 26.4 | 16.0 | 12.6 | 8 | BEARISH | 72.2 |
| GHRS GH Research PLC | $1.6B | -22.9 | -18.8 | 2015.5 | — | — | 2 | BEARISH | 69.0 |
| PRTA Prothena Corporation plc | $450M | -10.1 | -14.4 | -871.5 | -1839.9 | 427.3 | 5 | BEARISH | -15.7 |
| NBRVF Nabriva Therapeutics plc | — | — | — | — | — | — | — | BEARISH | -0.0 |
| ITRM Iterum Therapeutics plc | — | -0.1 | 285.5 | -104.4 | -2302.3 | — | 5 | N/A | -97.2 |
| JAZZ Jazz Pharmaceuticals plc | $15B | 15.5 | 22.1 | 26.4 | 16.0 | 12.6 | 8 | BEARISH | 72.2 |
| GHRS GH Research PLC | $1.6B | -22.9 | -18.8 | 2015.5 | — | — | 2 | BEARISH | 69.0 |
| PRTA Prothena Corporation plc | $450M | -10.1 | -14.4 | -871.5 | -1839.9 | 427.3 | 5 | BEARISH | -15.7 |
| NBRVF Nabriva Therapeutics plc | — | — | — | — | — | — | — | BEARISH | -0.0 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
ITRM vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
P/E Ratio
ROE
Piotroski F